Interim report January – March 2024 for CombiGene AB (publ)
January – March 2024Net sales: TSEK 326 (2,168).Other operating revenues: TSEK 1,042 (0).Profit from financial items:
January – March 2024Net sales: TSEK 326 (2,168).Other operating revenues: TSEK 1,042 (0).Profit from financial items:
January – March 2023• Net sales: TSEK 2,168 (11,403).• Other operating revenues: TSEK 0 (2,801).• Profit
Period January – March 2022• Net sales: 11,403 (0) TSEK.• Other operating revenues: 3,102 (5,118) TSEK.• Profit
Period January – March 2021• Net sales: 0 (0) TSEK.• Other operating revenues: 5 118 (4
First quarter January – March 2019 Nets sales: TSEK 0 (0). Other operating revenues TSEK 1,635
Read the report>> “This is an English translation of the Swedish website; if there is any